(MedPage Today) — At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on using resmetirom (Rezdiffra) and semaglutide (Ozempic, Wegovy) for metabolic dysfunction-associated steatohepatitis…
Source link : https://www.medpagetoday.com/meetingcoverage/aasldvideopearls/118532
Author :
Publish date : 2025-11-14 18:51:00
Copyright for syndicated content belongs to the linked Source.
